New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 1, 2013
08:56 EDTOPTROptimer downgraded to Market Perform from Outperform at JMP Securities
News For OPTR From The Last 14 Days
Check below for free stories on OPTR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 24, 2013
16:27 EDTOPTRJames Flynn reports 5.54% passive stake in Optimer
May 15, 2013
16:00 EDTOPTROptimer calls active following takeover report
Optimer (OPTR) May and June 17 calls are active on 5,600 contracts (500 puts) according to Track Data. Traders are taking positions for large price movement on Cubist (CBST) offered to buy the company for $20 per share, Reuters says.
15:54 EDTOPTROptimer up 12.5%, to $16.03 after Reuters report Cubist offered $20 per share
Subscribe for More Information
15:53 EDTOPTRCubist offered to buy Optimer for $20 per share, Reuters says
Subscribe for More Information
May 14, 2013
11:41 EDTOPTRHigh option volume stocks: DANG RLGY JNY TTWO OPTR
May 13, 2013
16:53 EDTOPTROptimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg says
Optimer (OPTR) has received first round bids from AstraZeneca (AZN), Cubist (CBST), and Astellas, reports Bloomberg, citing people familiar with the matter. Shares of Optimer spiked higher following the report, closing up $1.85, or 14.44%, to $14.66. The report notes the company disclosed almost three months ago it was exploring its strategic options. Reference Link
16:08 EDTOPTROptimer appoints Eric Sirota as COO
Optimer Pharmaceuticals announced the appointment of Eric Sirota as COO. Sirota has served as a consultant to the company since March 8.
15:56 EDTOPTROptimer jumps 13% to $14.43 after Bloomberg report on bidding process
Subscribe for More Information
15:55 EDTOPTROptimer gets first round bids from AstraZeneca, Cubist, Bloomberg says
Subscribe for More Information
10:58 EDTOPTRHigh option volume stocks: PRGO OMEX SCTY OPTR DNR
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.